Liposomes as nanocarriers for anti-HIV therapy
S Chopra, N Venkatesan, GV Betageri - Drug delivery and translational …, 2013 - Springer
Globally, in the last three decades of medical research, the use of liposomes as carrier for
anti-HIV/AIDS drugs is gaining prominence. These potential anti-HIV nanocarriers are …
anti-HIV/AIDS drugs is gaining prominence. These potential anti-HIV nanocarriers are …
Successful delivery of zidovudine-loaded docosanol nanostructured lipid carriers (docosanol NLCs) into rat brain
The major challenges to the clinical application of zidovudine are its moderate aqueous
solubility, relative short half-life, and incapability to go across BBB after systemic …
solubility, relative short half-life, and incapability to go across BBB after systemic …
Combination therapy of lamivudine and zidovudine using sterically stabilized liposomes: development and characterization
V Gavini - Asian Journal of Pharmaceutics (AJP), 2016 - asiapharmaceutics.info
Aim: Lamivudine and zidovudine are nucleoside reverse-transcriptase inhibitors with activity
against human immunodeficiency virus type 1 (HIV-1). However, only temporary and limited …
against human immunodeficiency virus type 1 (HIV-1). However, only temporary and limited …
Exploring the use of liposomal drug delivery system for antiretroviral drugs in HIV/AIDS therapy
MD Godbole, PM Sabale… - Research Journal of …, 2020 - indianjournals.com
Acquired Immunodeficiency Syndrome'is a collection of symptoms and opportunistic
infections from the specific damage to the immune system caused by the HIV. Highly Active …
infections from the specific damage to the immune system caused by the HIV. Highly Active …
[HTML][HTML] Exploring the use of liposomal drug delivery system for antiretroviral drugs in HIV/AIDS therapy
D Godbole Mangesh, M Sabale Prafulla… - rjptonline.org
Acquired Immunodeficiency Syndrome'is a collection of symptoms and opportunistic
infections from the specific damage to the immune system caused by the HIV. Highly Active …
infections from the specific damage to the immune system caused by the HIV. Highly Active …